Loading…

Metabolic and ultrastructural effects of cyclosporin A on pancreatic islets

We investigated the effect of different doses of cyclosporin A (CyA) on glucose and insulin levels, as well as its residual effects on pancreatic islets ultrastructure after discontinuation of the drug. We studied four groups of Wistar rats. One control- (n = 5) and three experimental groups, n = 10...

Full description

Saved in:
Bibliographic Details
Published in:Transplant international 1999-05, Vol.12 (3), p.208-212
Main Authors: BAKONYI NETO, A, HAAPALAINEN, E, NIGRO, A. T, FERREIRA, R, FEO, C. F, MISIAKO, E. P, VENNARECCI, G, PORCU, A, DIB, S. A, GOLDENBERG, S, GOMES, P. O
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c280t-6a85eea112a8563642993650fbaa1d976d53aa6c327aefe17cf7701cffbfa8a93
cites
container_end_page 212
container_issue 3
container_start_page 208
container_title Transplant international
container_volume 12
creator BAKONYI NETO, A
HAAPALAINEN, E
NIGRO, A. T
FERREIRA, R
FEO, C. F
MISIAKO, E. P
VENNARECCI, G
PORCU, A
DIB, S. A
GOLDENBERG, S
GOMES, P. O
description We investigated the effect of different doses of cyclosporin A (CyA) on glucose and insulin levels, as well as its residual effects on pancreatic islets ultrastructure after discontinuation of the drug. We studied four groups of Wistar rats. One control- (n = 5) and three experimental groups, n = 10 each, were treated with different doses of CyA i.m. for 14 days: group I, 5 mg/Kg; group II, 15 mg/Kg; and group III, 25 mg/Kg. Five animals of each group were sacrificed after 14 days, and the remaining five after 21 days to assess residual CyA effects. On the day of sacrifice, the rats underwent maltose absorption test, and glucose and insulin levels were measured. Pancreatic biopsies were obtained on day 21 to evaluate islets ultrastructure by electron microscopy. As a result, statistically significant, dose dependent (P < 0.05) increases in glucose and insulin levels were observed in CyA-treated groups. Groups II and III showed insulin levels significantly higher after fasting (P < 0.05) on day 14 comparing to the controls, while in groups I and II values returned to normal after CyA discontinuation. Group III showed persistently increased insulin levels on day 21. Pancreatic ultrastructural changes were observed only in group III. We can conclude that CyA effects on glucose and insulin levels were temporary and reversible at low doses. Ultrastructural changes in the pancreatic islets may occur with high doses of CyA.
doi_str_mv 10.1007/s001470050212
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_69925954</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69925954</sourcerecordid><originalsourceid>FETCH-LOGICAL-c280t-6a85eea112a8563642993650fbaa1d976d53aa6c327aefe17cf7701cffbfa8a93</originalsourceid><addsrcrecordid>eNpFzz1PwzAQBmALgWgpjKzIA2ILnL_ieKwqvkQRC8zRxbGlIDcJtjP03xNEEdPd8Lynewm5ZHDLAPRdAmBSAyjgjB-RJZOCF5xrfUyWYIQsoNJyQc5S-gQAXik4JQsGkhujzJK8vLqMzRA6S7Fv6RRyxJTjZPMUMVDnvbM50cFTu7dhSOMQu56u6dDTEXsbHeY52qXgcjonJx5DcheHuSIfD_fvm6di-_b4vFlvC8sryEWJlXIOGePzUory5xVRKvANImuNLlslEEsruEbnHdPWaw3Met94rNCIFbn5vTvG4WtyKde7LlkXAvZumFJdGsOVUXKGVwc4NTvX1mPsdhj39V_9GVwfACaLwce5Upf-XaW5FFJ8AxJoaXk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69925954</pqid></control><display><type>article</type><title>Metabolic and ultrastructural effects of cyclosporin A on pancreatic islets</title><source>Alma/SFX Local Collection</source><creator>BAKONYI NETO, A ; HAAPALAINEN, E ; NIGRO, A. T ; FERREIRA, R ; FEO, C. F ; MISIAKO, E. P ; VENNARECCI, G ; PORCU, A ; DIB, S. A ; GOLDENBERG, S ; GOMES, P. O</creator><creatorcontrib>BAKONYI NETO, A ; HAAPALAINEN, E ; NIGRO, A. T ; FERREIRA, R ; FEO, C. F ; MISIAKO, E. P ; VENNARECCI, G ; PORCU, A ; DIB, S. A ; GOLDENBERG, S ; GOMES, P. O</creatorcontrib><description>We investigated the effect of different doses of cyclosporin A (CyA) on glucose and insulin levels, as well as its residual effects on pancreatic islets ultrastructure after discontinuation of the drug. We studied four groups of Wistar rats. One control- (n = 5) and three experimental groups, n = 10 each, were treated with different doses of CyA i.m. for 14 days: group I, 5 mg/Kg; group II, 15 mg/Kg; and group III, 25 mg/Kg. Five animals of each group were sacrificed after 14 days, and the remaining five after 21 days to assess residual CyA effects. On the day of sacrifice, the rats underwent maltose absorption test, and glucose and insulin levels were measured. Pancreatic biopsies were obtained on day 21 to evaluate islets ultrastructure by electron microscopy. As a result, statistically significant, dose dependent (P &lt; 0.05) increases in glucose and insulin levels were observed in CyA-treated groups. Groups II and III showed insulin levels significantly higher after fasting (P &lt; 0.05) on day 14 comparing to the controls, while in groups I and II values returned to normal after CyA discontinuation. Group III showed persistently increased insulin levels on day 21. Pancreatic ultrastructural changes were observed only in group III. We can conclude that CyA effects on glucose and insulin levels were temporary and reversible at low doses. Ultrastructural changes in the pancreatic islets may occur with high doses of CyA.</description><identifier>ISSN: 0934-0874</identifier><identifier>EISSN: 1432-2277</identifier><identifier>DOI: 10.1007/s001470050212</identifier><identifier>PMID: 10429959</identifier><language>eng</language><publisher>Oxford: Blackwell Publishing</publisher><subject>Animals ; Biological and medical sciences ; Cyclosporine - administration &amp; dosage ; Cyclosporine - pharmacology ; Dose-Response Relationship, Drug ; Drug toxicity and drugs side effects treatment ; Glucose - metabolism ; Immunosuppressive Agents - administration &amp; dosage ; Immunosuppressive Agents - pharmacology ; Insulin - metabolism ; Islets of Langerhans - drug effects ; Islets of Langerhans - metabolism ; Islets of Langerhans - ultrastructure ; Medical sciences ; Microscopy, Electron ; Miscellaneous (drug allergy, mutagens, teratogens...) ; Pharmacology. Drug treatments ; Rats ; Rats, Wistar</subject><ispartof>Transplant international, 1999-05, Vol.12 (3), p.208-212</ispartof><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c280t-6a85eea112a8563642993650fbaa1d976d53aa6c327aefe17cf7701cffbfa8a93</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1872434$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10429959$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BAKONYI NETO, A</creatorcontrib><creatorcontrib>HAAPALAINEN, E</creatorcontrib><creatorcontrib>NIGRO, A. T</creatorcontrib><creatorcontrib>FERREIRA, R</creatorcontrib><creatorcontrib>FEO, C. F</creatorcontrib><creatorcontrib>MISIAKO, E. P</creatorcontrib><creatorcontrib>VENNARECCI, G</creatorcontrib><creatorcontrib>PORCU, A</creatorcontrib><creatorcontrib>DIB, S. A</creatorcontrib><creatorcontrib>GOLDENBERG, S</creatorcontrib><creatorcontrib>GOMES, P. O</creatorcontrib><title>Metabolic and ultrastructural effects of cyclosporin A on pancreatic islets</title><title>Transplant international</title><addtitle>Transpl Int</addtitle><description>We investigated the effect of different doses of cyclosporin A (CyA) on glucose and insulin levels, as well as its residual effects on pancreatic islets ultrastructure after discontinuation of the drug. We studied four groups of Wistar rats. One control- (n = 5) and three experimental groups, n = 10 each, were treated with different doses of CyA i.m. for 14 days: group I, 5 mg/Kg; group II, 15 mg/Kg; and group III, 25 mg/Kg. Five animals of each group were sacrificed after 14 days, and the remaining five after 21 days to assess residual CyA effects. On the day of sacrifice, the rats underwent maltose absorption test, and glucose and insulin levels were measured. Pancreatic biopsies were obtained on day 21 to evaluate islets ultrastructure by electron microscopy. As a result, statistically significant, dose dependent (P &lt; 0.05) increases in glucose and insulin levels were observed in CyA-treated groups. Groups II and III showed insulin levels significantly higher after fasting (P &lt; 0.05) on day 14 comparing to the controls, while in groups I and II values returned to normal after CyA discontinuation. Group III showed persistently increased insulin levels on day 21. Pancreatic ultrastructural changes were observed only in group III. We can conclude that CyA effects on glucose and insulin levels were temporary and reversible at low doses. Ultrastructural changes in the pancreatic islets may occur with high doses of CyA.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Cyclosporine - administration &amp; dosage</subject><subject>Cyclosporine - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Glucose - metabolism</subject><subject>Immunosuppressive Agents - administration &amp; dosage</subject><subject>Immunosuppressive Agents - pharmacology</subject><subject>Insulin - metabolism</subject><subject>Islets of Langerhans - drug effects</subject><subject>Islets of Langerhans - metabolism</subject><subject>Islets of Langerhans - ultrastructure</subject><subject>Medical sciences</subject><subject>Microscopy, Electron</subject><subject>Miscellaneous (drug allergy, mutagens, teratogens...)</subject><subject>Pharmacology. Drug treatments</subject><subject>Rats</subject><subject>Rats, Wistar</subject><issn>0934-0874</issn><issn>1432-2277</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNpFzz1PwzAQBmALgWgpjKzIA2ILnL_ieKwqvkQRC8zRxbGlIDcJtjP03xNEEdPd8Lynewm5ZHDLAPRdAmBSAyjgjB-RJZOCF5xrfUyWYIQsoNJyQc5S-gQAXik4JQsGkhujzJK8vLqMzRA6S7Fv6RRyxJTjZPMUMVDnvbM50cFTu7dhSOMQu56u6dDTEXsbHeY52qXgcjonJx5DcheHuSIfD_fvm6di-_b4vFlvC8sryEWJlXIOGePzUory5xVRKvANImuNLlslEEsruEbnHdPWaw3Met94rNCIFbn5vTvG4WtyKde7LlkXAvZumFJdGsOVUXKGVwc4NTvX1mPsdhj39V_9GVwfACaLwce5Upf-XaW5FFJ8AxJoaXk</recordid><startdate>19990501</startdate><enddate>19990501</enddate><creator>BAKONYI NETO, A</creator><creator>HAAPALAINEN, E</creator><creator>NIGRO, A. T</creator><creator>FERREIRA, R</creator><creator>FEO, C. F</creator><creator>MISIAKO, E. P</creator><creator>VENNARECCI, G</creator><creator>PORCU, A</creator><creator>DIB, S. A</creator><creator>GOLDENBERG, S</creator><creator>GOMES, P. O</creator><general>Blackwell Publishing</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19990501</creationdate><title>Metabolic and ultrastructural effects of cyclosporin A on pancreatic islets</title><author>BAKONYI NETO, A ; HAAPALAINEN, E ; NIGRO, A. T ; FERREIRA, R ; FEO, C. F ; MISIAKO, E. P ; VENNARECCI, G ; PORCU, A ; DIB, S. A ; GOLDENBERG, S ; GOMES, P. O</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c280t-6a85eea112a8563642993650fbaa1d976d53aa6c327aefe17cf7701cffbfa8a93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Cyclosporine - administration &amp; dosage</topic><topic>Cyclosporine - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Glucose - metabolism</topic><topic>Immunosuppressive Agents - administration &amp; dosage</topic><topic>Immunosuppressive Agents - pharmacology</topic><topic>Insulin - metabolism</topic><topic>Islets of Langerhans - drug effects</topic><topic>Islets of Langerhans - metabolism</topic><topic>Islets of Langerhans - ultrastructure</topic><topic>Medical sciences</topic><topic>Microscopy, Electron</topic><topic>Miscellaneous (drug allergy, mutagens, teratogens...)</topic><topic>Pharmacology. Drug treatments</topic><topic>Rats</topic><topic>Rats, Wistar</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BAKONYI NETO, A</creatorcontrib><creatorcontrib>HAAPALAINEN, E</creatorcontrib><creatorcontrib>NIGRO, A. T</creatorcontrib><creatorcontrib>FERREIRA, R</creatorcontrib><creatorcontrib>FEO, C. F</creatorcontrib><creatorcontrib>MISIAKO, E. P</creatorcontrib><creatorcontrib>VENNARECCI, G</creatorcontrib><creatorcontrib>PORCU, A</creatorcontrib><creatorcontrib>DIB, S. A</creatorcontrib><creatorcontrib>GOLDENBERG, S</creatorcontrib><creatorcontrib>GOMES, P. O</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Transplant international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BAKONYI NETO, A</au><au>HAAPALAINEN, E</au><au>NIGRO, A. T</au><au>FERREIRA, R</au><au>FEO, C. F</au><au>MISIAKO, E. P</au><au>VENNARECCI, G</au><au>PORCU, A</au><au>DIB, S. A</au><au>GOLDENBERG, S</au><au>GOMES, P. O</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metabolic and ultrastructural effects of cyclosporin A on pancreatic islets</atitle><jtitle>Transplant international</jtitle><addtitle>Transpl Int</addtitle><date>1999-05-01</date><risdate>1999</risdate><volume>12</volume><issue>3</issue><spage>208</spage><epage>212</epage><pages>208-212</pages><issn>0934-0874</issn><eissn>1432-2277</eissn><abstract>We investigated the effect of different doses of cyclosporin A (CyA) on glucose and insulin levels, as well as its residual effects on pancreatic islets ultrastructure after discontinuation of the drug. We studied four groups of Wistar rats. One control- (n = 5) and three experimental groups, n = 10 each, were treated with different doses of CyA i.m. for 14 days: group I, 5 mg/Kg; group II, 15 mg/Kg; and group III, 25 mg/Kg. Five animals of each group were sacrificed after 14 days, and the remaining five after 21 days to assess residual CyA effects. On the day of sacrifice, the rats underwent maltose absorption test, and glucose and insulin levels were measured. Pancreatic biopsies were obtained on day 21 to evaluate islets ultrastructure by electron microscopy. As a result, statistically significant, dose dependent (P &lt; 0.05) increases in glucose and insulin levels were observed in CyA-treated groups. Groups II and III showed insulin levels significantly higher after fasting (P &lt; 0.05) on day 14 comparing to the controls, while in groups I and II values returned to normal after CyA discontinuation. Group III showed persistently increased insulin levels on day 21. Pancreatic ultrastructural changes were observed only in group III. We can conclude that CyA effects on glucose and insulin levels were temporary and reversible at low doses. Ultrastructural changes in the pancreatic islets may occur with high doses of CyA.</abstract><cop>Oxford</cop><pub>Blackwell Publishing</pub><pmid>10429959</pmid><doi>10.1007/s001470050212</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0934-0874
ispartof Transplant international, 1999-05, Vol.12 (3), p.208-212
issn 0934-0874
1432-2277
language eng
recordid cdi_proquest_miscellaneous_69925954
source Alma/SFX Local Collection
subjects Animals
Biological and medical sciences
Cyclosporine - administration & dosage
Cyclosporine - pharmacology
Dose-Response Relationship, Drug
Drug toxicity and drugs side effects treatment
Glucose - metabolism
Immunosuppressive Agents - administration & dosage
Immunosuppressive Agents - pharmacology
Insulin - metabolism
Islets of Langerhans - drug effects
Islets of Langerhans - metabolism
Islets of Langerhans - ultrastructure
Medical sciences
Microscopy, Electron
Miscellaneous (drug allergy, mutagens, teratogens...)
Pharmacology. Drug treatments
Rats
Rats, Wistar
title Metabolic and ultrastructural effects of cyclosporin A on pancreatic islets
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T14%3A07%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metabolic%20and%20ultrastructural%20effects%20of%20cyclosporin%20A%20on%20pancreatic%20islets&rft.jtitle=Transplant%20international&rft.au=BAKONYI%20NETO,%20A&rft.date=1999-05-01&rft.volume=12&rft.issue=3&rft.spage=208&rft.epage=212&rft.pages=208-212&rft.issn=0934-0874&rft.eissn=1432-2277&rft_id=info:doi/10.1007/s001470050212&rft_dat=%3Cproquest_pubme%3E69925954%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c280t-6a85eea112a8563642993650fbaa1d976d53aa6c327aefe17cf7701cffbfa8a93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=69925954&rft_id=info:pmid/10429959&rfr_iscdi=true